Presbyterian Hospital

Futó vizsgálatok

• Toboroz

  Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

  NCT07022678· 3. fázis· Forrás

• Toboroz

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT06124157· 2. fázis· Forrás

• Toboroz

  A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  NCT06401330· 3. fázis· Forrás

• Toboroz

  Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

  NCT06513962· 3. fázis· Forrás

• Fut, nem toboroz

  Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

  NCT05602194· 3. fázis· Forrás

• Toboroz

  A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  NCT05675410· 3. fázis· Forrás

• Toboroz

  Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  NCT05235165· 3. fázis· Forrás

• Fut, nem toboroz

  Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

  NCT04759586· 3. fázis· Forrás

• Toboroz

  A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT04546399· 2. fázis· Forrás

• Toboroz

  A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  NCT04322318· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

  NCT03871257· 3. fázis· Forrás

• Toboroz

  Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  NCT03959085· 3. fázis· Forrás

• Fut, nem toboroz

  Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

  NCT03907488· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

  NCT03914625· 3. fázis· Forrás

• Fut, nem toboroz

  Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

  NCT03007147· 3. fázis· Forrás

• Toboroz

  Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

  NCT03067181· 3. fázis· Forrás

• Fut, nem toboroz

  Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  NCT02567435· 3. fázis· Forrás

• Fut, nem toboroz

  Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

  NCT02521493· 3. fázis· Forrás

• Toboroz

  Project: Every Child for Younger Patients With Cancer

  NCT02402244· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok11 toboroz
• Akut limfoid leukémia (ALL)3 toboroz
• Petefészekrák2 toboroz
• Vesedaganat2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Szarkóma1 toboroz
• Tüdőrák1 toboroz

Kutatók

Ide még nem kötődik kutató.